What is the appropriate post‑exposure prophylaxis for a healthy 5‑month‑old infant exposed to measles in the household?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Exposure Measles Prophylaxis for a 5-Month-Old Infant

Administer immune globulin (IG) intramuscularly at 0.25 mL/kg (maximum 15 mL) as soon as possible, ideally within 6 days of exposure. 1

Rationale for Immune Globulin Administration

  • Infants under 6 months of age are specifically indicated for IG prophylaxis when they are household contacts of measles patients, as they are at highest risk for severe complications and mortality from measles. 1, 2

  • The standard dose is 0.25 mL/kg intramuscularly (maximum 15 mL) for immunocompetent infants, though some recent evidence suggests 0.5 mL/kg may provide better protection given declining antibody concentrations in modern IG preparations. 1, 3, 4

  • IG can prevent or modify measles infection if administered within 6 days of exposure, making prompt administration critical. 1, 2

Why Not Vaccination at 5 Months?

  • Measles vaccine is not recommended below 6 months of age because maternal antibodies interfere with vaccine response, leading to poor immunogenicity and high vaccine failure rates. 1, 2

  • Even when vaccine can be given (≥6 months), it is only effective as post-exposure prophylaxis within 72 hours of initial exposure. 1, 2 In household settings, measles is typically not recognized until after this window has passed. 1

  • For household contacts aged ≥6 months, vaccine within 72 hours is acceptable, but if that window is missed, IG becomes the recommended intervention. 1

Why Not Acyclovir?

  • Acyclovir has no role in measles prophylaxis or treatment—measles is caused by a paramyxovirus, not a herpesvirus. This option represents a fundamental misunderstanding of viral pathogens.

Critical Follow-Up

  • Any infant who receives IG must subsequently receive MMR vaccine starting at 12 months of age, administered no earlier than 5-6 months after IG administration. 1, 2

  • This delayed vaccination schedule is necessary because passively acquired measles antibodies from IG interfere with the immune response to live measles vaccination. 1, 2

  • The infant should receive the standard 2-dose MMR series: first dose at 12-15 months and second dose at 4-6 years before school entry. 2, 5

Important Caveats

  • Infants under 6 months are usually immune due to passively acquired maternal antibodies, but if the mother herself has measles, this protection cannot be assumed and IG should be given to all unvaccinated household contacts regardless of age. 1

  • The effectiveness of IG depends on the concentration of measles antibodies in the product, which has declined over time as more donors have vaccine-derived rather than natural immunity. 3, 4, 6 Recent studies show modern IG preparations remain effective when dosed appropriately. 7, 4

  • Do not delay IG administration while waiting for maternal antibody testing—the 6-day window is critical, and testing results may not return in time. 7

Answer: B. Immunoglobulins

References

Related Questions

What is the protocol for immunization during a measles outbreak?
What is the recommended dose and administration of Immune Globulin (IG) for post-exposure prophylaxis against measles?
What prophylaxis should be given to a 5‑month‑old infant who has been exposed to measles from his 6‑year‑old sibling?
What are the immediate recommendations for a patient without a Measles, Mumps, and Rubella (MMR) record on file who has been exposed to measles?
Can the measles virus stay on clothes?
How is Rh‑D (Rhd) status assessed and what are the management recommendations for Rh‑negative individuals, especially regarding blood transfusion and Rh immunoglobulin prophylaxis during pregnancy?
How should an adult with chronic heart failure with reduced ejection fraction be managed when he presents with an acute decompensation precipitated by influenza infection?
How does ileal disease (e.g., Crohn’s disease) or surgical resection of the terminal ileum deplete the bile acid pool and create lithogenic bile?
In a 20‑year‑old woman with a first episode of optic neuritis, should I perform lumbar puncture with cerebrospinal fluid analysis and serum AQP4‑IgG (neuromyelitis optica antibody) and MOG‑IgG testing?
How should I manage a patient with rheumatic heart disease, including secondary prophylaxis, monitoring, and treatment of valve lesions and heart failure?
For influenza, how long does viral shedding and contagiousness persist in healthy adults compared to children, pregnant women, the elderly, or immunocompromised patients, and how does antiviral therapy (e.g., oseltamivir) alter this period?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.